Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Functional and structural plasticity following action observation training in multiple sclerosis.

Rocca MA, Meani A, Fumagalli S, Pagani E, Gatti R, Martinelli-Boneschi F, Esposito F, Preziosa P, Cordani C, Comi G, Filippi M.

Mult Scler. 2018 Aug 7:1352458518792771. doi: 10.1177/1352458518792771. [Epub ahead of print]

PMID:
30084706
2.

Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.

Gelibter S, Mazzi B, Tassara M, Colombo B, Guerrieri S, Giordano A, Preziosa P, Comola M, Esposito F, Martinelli V, Rocca MA, Comi G, Leocani L, Martinelli-Boneschi F.

Mult Scler Relat Disord. 2018 Jul 24;25:73-76. doi: 10.1016/j.msard.2018.07.017. [Epub ahead of print]

PMID:
30053751
3.

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.

Romeo MAL, Martinelli V, Dalla Costa G, Colombo B, De Feo D, Esposito F, Ferrè L, Guaschino C, Guerrieri S, Liberatore G, Martinelli Boneschi F, Merlini A, Messina M, Messina R, Nuara A, Preziosa P, Radaelli M, Rocca MA, Rodegher M, Sangalli F, Strambo D, Moiola L, Comi G.

Acta Neurol Scand. 2018 Jul 22. doi: 10.1111/ane.12999. [Epub ahead of print]

PMID:
30033621
4.

Laser capture microdissection for transcriptomic profiles in human skin biopsies.

Santoro S, Lopez ID, Lombardi R, Zauli A, Osiceanu AM, Sorosina M, Clarelli F, Peroni S, Cazzato D, Marchi M, Quattrini A, Comi G, Calogero RA, Lauria G, Martinelli Boneschi F.

BMC Mol Biol. 2018 Jun 19;19(1):7. doi: 10.1186/s12867-018-0108-5.

5.

Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Jia X, Madireddy L, Caillier S, Santaniello A, Esposito F, Comi G, Stuve O, Zhou Y, Taylor B, Kilpatrick T, Martinelli-Boneschi F, Cree BAC, Oksenberg JR, Hauser SL, Baranzini SE.

Ann Neurol. 2018 Jun 16. doi: 10.1002/ana.25263. [Epub ahead of print]

PMID:
29908077
6.

Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.

Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.

Neurol Sci. 2018 Aug;39(8):1467-1470. doi: 10.1007/s10072-018-3440-0. Epub 2018 May 13.

PMID:
29756179
7.

Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.

Sorosina M, Clarelli F, Ferrè L, Osiceanu AM, Unal NT, Mascia E, Martinelli V, Comi G, Benigni F, Esposito F, Martinelli Boneschi F.

Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.

PMID:
29528549
8.

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients.

Esposito F, Ferrè L, Clarelli F, Rocca MA, Sferruzza G, Storelli L, Radaelli M, Sangalli F, Moiola L, Colombo B, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V.

J Neurol. 2018 Apr;265(4):896-905. doi: 10.1007/s00415-018-8791-1. Epub 2018 Feb 12.

PMID:
29435643
9.

NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

Malhotra S, Sorosina M, Río J, Peroni S, Midaglia L, Villar LM, Álvarez-Cermeño JC, Schroeder I, Esposito F, Clarelli F, Zettl UK, Lechner-Scott J, Spataro N, Navarro A, Comi G, Montalban X, Martinelli-Boneschi F, Comabella M.

Mult Scler. 2017 Nov 1:1352458517739137. doi: 10.1177/1352458517739137. [Epub ahead of print]

10.

Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations.

Trudu M, Schaeffer C, Riba M, Ikehata M, Brambilla P, Messa P, Martinelli-Boneschi F, Rastaldi MP, Rampoldi L.

Sci Rep. 2017 Aug 7;7(1):7383. doi: 10.1038/s41598-017-07804-6.

11.

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Clemente N, Comi C, Raineri D, Cappellano G, Vecchio D, Orilieri E, Gigliotti CL, Boggio E, Dianzani C, Sorosina M, Martinelli-Boneschi F, Caldano M, Bertolotto A, Ambrogio L, Sblattero D, Cena T, Leone M, Dianzani U, Chiocchetti A.

Front Immunol. 2017 Mar 23;8:321. doi: 10.3389/fimmu.2017.00321. eCollection 2017.

12.

Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment.

Rocca MA, Valsasina P, Leavitt VM, Rodegher M, Radaelli M, Riccitelli GC, Martinelli V, Martinelli-Boneschi F, Falini A, Comi G, Filippi M.

Mult Scler. 2018 Apr;24(4):459-471. doi: 10.1177/1352458517699875. Epub 2017 Mar 15.

PMID:
28294693
13.

Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.

Dianzani C, Bellavista E, Liepe J, Verderio C, Martucci M, Santoro A, Chiocchetti A, Gigliotti CL, Boggio E, Ferrara B, Riganti L, Keller C, Janek K, Niewienda A, Fenoglio C, Sorosina M, Cantello R, Kloetzel PM, Stumpf MP, Paul F, Ruprecht K, Galimberti D, Martinelli Boneschi F, Comi C, Dianzani U, Mishto M.

Sci Rep. 2017 Mar 9;7:43718. doi: 10.1038/srep43718.

14.

COL6A5 variants in familial neuropathic chronic itch.

Martinelli-Boneschi F, Colombi M, Castori M, Devigili G, Eleopra R, Malik RA, Ritelli M, Zoppi N, Dordoni C, Sorosina M, Grammatico P, Fadavi H, Gerrits MM, Almomani R, Faber CG, Merkies IS, Toniolo D; INGI Network, Cocca M, Doglioni C, Waxman SG, Dib-Hajj SD, Taiana MM, Sassone J, Lombardi R, Cazzato D, Zauli A, Santoro S, Marchi M, Lauria G.

Brain. 2017 Mar 1;140(3):555-567. doi: 10.1093/brain/aww343.

PMID:
28073787
15.

Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis.

Riva N, Clarelli F, Domi T, Cerri F, Gallia F, Trimarco A, Brambilla P, Lunetta C, Lazzerini A, Lauria G, Taveggia C, Iannaccone S, Nobile-Orazio E, Comi G, D'Antonio M, Martinelli-Boneschi F, Quattrini A.

Sci Rep. 2016 Dec 16;6:39297. doi: 10.1038/srep39297.

16.

Functional Characterization of the Left Ventrolateral Premotor Cortex in Humans: A Direct Electrophysiological Approach.

Fornia L, Ferpozzi V, Montagna M, Rossi M, Riva M, Pessina F, Martinelli Boneschi F, Borroni P, Lemon RN, Bello L, Cerri G.

Cereb Cortex. 2018 Jan 1;28(1):167-183. doi: 10.1093/cercor/bhw365.

PMID:
27920095
17.

Next Generation Sequencing of Pooled Samples: Guideline for Variants' Filtering.

Anand S, Mangano E, Barizzone N, Bordoni R, Sorosina M, Clarelli F, Corrado L, Martinelli Boneschi F, D'Alfonso S, De Bellis G.

Sci Rep. 2016 Sep 27;6:33735. doi: 10.1038/srep33735.

18.

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.

George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Søndergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BA, Oksenberg JR, Hauser SL, D'Alfonso S, Leone MA, Martinelli Boneschi F, Sorosina M, van der Mei I, Taylor BV, Zhou Y, Schaefer C, Barcellos LF.

Neurol Genet. 2016 Aug 4;2(4):e87. doi: 10.1212/NXG.0000000000000087. eCollection 2016 Aug.

19.

Assessing Functional Decline in Neurological Diseases Clinical Trials: Duration of Follow-Up - The Case of Multiple Sclerosis.

Martinelli Boneschi F, Comi G.

Front Neurol Neurosci. 2016;39:93-100. doi: 10.1159/000445418. Epub 2016 Jul 26. Review.

PMID:
27463522
20.

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.

Clarelli F, Mascia E, Santangelo R, Mazzeo S, Giacalone G, Galimberti D, Fusco F, Zuffi M, Fenoglio C, Franceschi M, Scarpini E, Forloni G, Magnani G, Comi G, Albani D, Martinelli Boneschi F.

J Alzheimers Dis. 2016 Apr 16;52(4):1203-8. doi: 10.3233/JAD-160074.

PMID:
27104904

Supplemental Content

Loading ...
Support Center